{"id":32825,"date":"2026-07-08T17:00:00","date_gmt":"2026-07-08T15:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=822ecf6d007be497d7205107bf13a01a"},"modified":"2026-07-08T17:00:00","modified_gmt":"2026-07-08T15:00:00","slug":"incyte-to-report-second-quarter-financial-results","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=32825","title":{"rendered":"Incyte to Report Second Quarter Financial Results"},"content":{"rendered":"<p>WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 28, 2026.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260708563739\/en\/1078784\/5\/Incyte_Color_Logo_JPEG_2colorpos.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260708563739\/en\/1078784\/22\/Incyte_Color_Logo_JPEG_2colorpos.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260708563739\/en\/1078784\/5\/Incyte_Color_Logo_JPEG_2colorpos.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260708563739\/en\/1078784\/21\/Incyte_Color_Logo_JPEG_2colorpos.jpg\" \/><\/a><p>\nThe schedule for the press release and conference call\/webcast is as follows:<\/p><ul class=\"bwlistdisc\">\n<li>\nQ2 2026 Press Release: July 28, 2026, at 7:00 a.m. ET<\/li>\n<li>\nQ2 2026 Conference Call: July 28, 2026, at 8:00 a.m. ET<\/li>\n<li>\nDomestic Dial-In Number: 877-407-3042<\/li>\n<li>\nInternational Dial-In Number: 201-389-0864<\/li>\n<li>\nConference ID Number: 13759527<\/li>\n<\/ul><p>\nIf you are unable to participate, a replay of the conference will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference identification number 13759527.<\/p><p>\nA live webcast with slides can be accessed at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2FInvestor.Incyte.com&amp;esheet=54566125&amp;newsitemid=20260708563739&amp;lan=en-US&amp;anchor=Investor.Incyte.com&amp;index=1&amp;md5=773959677ae550d669c6fb73b0b41289\" rel=\"nofollow\" shape=\"rect\">Investor.Incyte.com<\/a> and will be available for replay for ninety days.<\/p><p>\n<b>About Incyte\n<br\/><\/b>Incyte is redefining what\u2019s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation &amp; Autoimmunity.<\/p><p>\nTo learn more, visit <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.incyte.com%2F&amp;esheet=54566125&amp;newsitemid=20260708563739&amp;lan=en-US&amp;anchor=Incyte.com&amp;index=2&amp;md5=b126be31d11e5da8efaa0e55397304f7\" rel=\"nofollow\" shape=\"rect\">Incyte.com<\/a> and <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestor.incyte.com%2F&amp;esheet=54566125&amp;newsitemid=20260708563739&amp;lan=en-US&amp;anchor=Investor.Incyte.com&amp;index=3&amp;md5=9bb1369fef55cc8f2d1b00668814a9ca\" rel=\"nofollow\" shape=\"rect\">Investor.Incyte.com<\/a>. Follow us on social media: <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fincyte%2F&amp;esheet=54566125&amp;newsitemid=20260708563739&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=d449969b962607a727f82006eb3aba3a\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a>, <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2FIncyte&amp;esheet=54566125&amp;newsitemid=20260708563739&amp;lan=en-US&amp;anchor=X&amp;index=5&amp;md5=4e60f5043b90c8ecda2e163e54cc34c9\" rel=\"nofollow\" shape=\"rect\">X<\/a>, and <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fincyte%2F&amp;esheet=54566125&amp;newsitemid=20260708563739&amp;lan=en-US&amp;anchor=Instagram&amp;index=6&amp;md5=418b176b1b3729925dfc58da1504fb51\" rel=\"nofollow\" shape=\"rect\">Instagram<\/a>.<\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b><span class=\"bwuline\">Incyte Contacts<\/span><\/b><br\/><b>Media<\/b><br\/><a  href=\"mailto:media@incyte.com\" rel=\"nofollow\" shape=\"rect\">media@incyte.com<\/a><\/p><p>\n<b>Investors<\/b><br\/><a  href=\"mailto:ir@incyte.com\" rel=\"nofollow\" shape=\"rect\">ir@incyte.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>WILMINGTON, Del.&#8211;(BUSINESS WIRE)&#8211;Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 28, 2026.<br \/>\nThe schedule for the press release and conference&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-32825","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32825"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32825\/revisions"}],"predecessor-version":[{"id":32826,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32825\/revisions\/32826"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}